Lisata Therapeutics Inc. (LSTA) — Cash Flow-to-Debt Ratio
Lisata Therapeutics Inc. (LSTA) has a Cash Flow-to-Debt Ratio of -0.72x as of September 2025, meaning its operating cash flow of $-3.34 Million could theoretically repay -1% of its total liabilities ($4.64 Million) in one year. See cash generation quality of Lisata Therapeutics Inc. to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Lisata Therapeutics Inc. Cash Flow-to-Debt Ratio (1993–2024)
Historical debt coverage capacity for Lisata Therapeutics Inc. across 31 annual periods. Also explore Lisata Therapeutics Inc. equity growth rate to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Lisata Therapeutics Inc. (1993–2024)
Year-by-year debt coverage analysis for Lisata Therapeutics Inc.. For market capitalisation and broader financial context, see market value of Lisata Therapeutics Inc..
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -3.40x | $-19.36 Million | $5.68 Million | ▼ -15.6% |
| 2023 | -2.95x | $-20.03 Million | $6.80 Million | ▲ +6.6% |
| 2022 | -3.15x | $-21.17 Million | $6.71 Million | ▲ +29.0% |
| 2021 | -4.44x | $-22.25 Million | $5.01 Million | ▼ -89.3% |
| 2020 | -2.35x | $-8.82 Million | $3.76 Million | ▲ +18.0% |
| 2019 | -2.86x | $-18.88 Million | $6.60 Million | ▼ -2.0% |
| 2018 | -2.80x | $-19.99 Million | $7.13 Million | ▼ -77.2% |
| 2017 | -1.58x | $-20.88 Million | $13.19 Million | ▼ -219.5% |
| 2016 | -0.50x | $-23.67 Million | $47.77 Million | ▲ +57.2% |
| 2015 | -1.16x | $-39.26 Million | $33.92 Million | ▼ -68.3% |
| 2014 | -0.69x | $-46.90 Million | $68.20 Million | ▲ +29.5% |
| 2013 | -0.98x | $-27.10 Million | $27.79 Million | ▼ -52.0% |
| 2012 | -0.64x | $-13.85 Million | $21.59 Million | ▼ -130.6% |
| 2011 | -0.28x | $-20.93 Million | $75.20 Million | ▼ -85.6% |
| 2010 | -0.15x | $-8.48 Million | $56.54 Million | ▲ +19.5% |
| 2009 | -0.19x | $-8.65 Million | $46.45 Million | ▲ +96.2% |
| 2008 | -4.92x | $-4.73 Million | $961.14K | ▲ +63.2% |
| 2007 | -13.36x | $-6.13 Million | $458.95K | ▼ -231.5% |
| 2006 | -4.03x | $-3.64 Million | $902.87K | ▼ -1089.0% |
| 2005 | -0.34x | $-834.00K | $2.46 Million | ▲ +52.8% |
| 2004 | -0.72x | $-1.46 Million | $2.03 Million | ▼ -27.6% |
| 2003 | -0.56x | $-1.02 Million | $1.81 Million | ▼ -212.4% |
| 2002 | 0.50x | $1.01 Million | $2.01 Million | ▲ +296.0% |
| 2001 | -0.26x | $-373.84K | $1.46 Million | ▲ +80.8% |
| 2000 | -1.33x | $-1.98 Million | $1.49 Million | ▼ -355.6% |
| 1999 | -0.29x | $-364.12K | $1.25 Million | ▼ -31.3% |
| 1998 | -0.22x | $-269.60K | $1.21 Million | ▲ +51.3% |
| 1996 | -0.46x | $-304.27K | $666.62K | ▲ +75.2% |
| 1995 | -1.84x | $-838.44K | $455.31K | ▼ -2684.2% |
| 1994 | -0.07x | $-840.00K | $12.70 Million | ▼ -208.4% |
| 1993 | 0.06x | $470.00K | $7.70 Million | — |